ONVO Stock, Organovo Holdings Inc. Information

Organovo designs and creates functional human tissues using a proprietary three dimensional bioprinting technology. The Company focuses on developing a range of human tissues and disease models for medical research and therapeutic applications. The Company s NovoGen three dimensional bioprinting technology employs a specialized automated platform that works across all tissue and cell types. Organovo s bioprinter was named one of the Best Inventions of by TIME Magazine and Organovo has been recognized as one of the most innovative companies of by MIT s Technology Review. Organovo is helping pharmaceutical partners develop never before available human biological disease models in three dimensions that hold the potential to transform the business of therapeutic drug discovery and development. Organovo is also developing direct tissue therapies where precise structure and architecture may deliver the best clinical outcomes. Organovo leads the way in solving complex medical research problems and building the future of medicine.